Invention Grant
- Patent Title: Selective PI3K delta inhibitors
-
Application No.: US15283515Application Date: 2016-10-03
-
Publication No.: US09669033B2Publication Date: 2017-06-06
- Inventor: Swaroop Kumar V. S. Vakkalanka , Meyyappan Muthuppalaniappan , Dhanapalan Nagarathnam
- Applicant: Rhizen Pharmaceuticals SA
- Applicant Address: CH La Chaux-de-Fonds
- Assignee: RHIZEN PHARMACEUTICALS SA
- Current Assignee: RHIZEN PHARMACEUTICALS SA
- Current Assignee Address: CH La Chaux-de-Fonds
- Agency: Blank Rome LLP
- Priority: IN2692/CHE/2012 20120704; IN2693/CHE/2012 20120704
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; A61P35/00 ; A61P35/02 ; A61K45/06
Abstract:
The present invention relates to selective inhibitors of PI3K delta protein kinases, methods of preparing them, pharmaceutical compositions containing them and methods of treatment and/or prevention of kinase mediated diseases or disorders with them.
Public/Granted literature
- US20170020881A1 NOVEL SELECTIVE PI3K DELTA INHIBITORS Public/Granted day:2017-01-26
Information query
